Literature DB >> 4362516

Transcription and replication of vesicular stomatitis virus: effects of temperature-sensitive mutations in complementation group IV.

A Combard, C Martinet, C Printz Ane, A Friedman, P Printz.   

Abstract

Temperature-sensitive (ts) mutants of vesicular stomatitis virus belonging to the RNA(-) complementation group IV were investigated under various conditions to study both their RNA and protein syntheses. In infected cells maintained at 39.2 C, viral RNA species were recovered only in the 13 to 15S region of the gradient in an amount depending on the ts mutant used. In the presence of cycloheximide at 39.2 C, the primary transcription was deficient, especially for 28S mRNA production. When mutant-infected cells were shifted to nonpermissive temperature, a shutoff of 28S mRNA synthesis occurred as a general feature. On the contrary under this condition, the two mutants chosen, ts IV100 and ts IV111, behaved very differently in their 13 to 15S and 38S RNA production. However, treatment with cycloheximide at the time of the transfer to 39.2 C resulted in a similar recovery of 13 to 15S RNA in both mutants, whereas the 28S remained very depressed. The viral proteins synthesized by cells infected with the same two mutants also showed a distinct pattern, especially regarding the N protein; a correlation between 38S RNA and protein N syntheses was tentatively drawn. The whole set of data suggested that the lesion in group IV mutants concerned a viral structural protein required for the process of in vivo transcription and which probably intervened in the replication mechanism.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4362516      PMCID: PMC355391     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  30 in total

1.  Ribonucleic acid synthesis of vesicular stomatitis virus. IV. Transcription by standard virus in the presence of defective interfering particles.

Authors:  A S Huang; E K Manders
Journal:  J Virol       Date:  1972-06       Impact factor: 5.103

2.  Proteins of vesicular stomatitis virus. 3. Intracellular synthesis and extracellular appearance of virus-specific proteins.

Authors:  C Y Kang; L Prevec
Journal:  Virology       Date:  1971-12       Impact factor: 3.616

3.  Genome homology of vesicular stomatitis virus and defective T particles and evidence for the sequential transcription of the virion ribonucleic acid.

Authors:  P Roy; D H Bishop
Journal:  J Virol       Date:  1972-06       Impact factor: 5.103

4.  The homologies of spontaneous and induced temperature-sensitive mutants of vesicular stomatitis virus isolated in chick embryo and BHK 21 cells.

Authors:  A Flamand; C R Pringle
Journal:  J Gen Virol       Date:  1971-05       Impact factor: 3.891

5.  Polysomal ribonucleic acid of vesicular stomatitis virus-infected HeLa cells.

Authors:  J A Mudd; D F Summers
Journal:  Virology       Date:  1970-12       Impact factor: 3.616

6.  Kinetics of RNA synthesis by vesicular stomatitis virus particles.

Authors:  D H Bishop; P Roy
Journal:  J Mol Biol       Date:  1971-05-14       Impact factor: 5.469

7.  Temperature-sensitive mutants of vesicular stomatitis virus: synthesis of virus-specific proteins.

Authors:  P Printz; R R Wagner
Journal:  J Virol       Date:  1971-05       Impact factor: 5.103

8.  Dissociation of vesicular stomatitis virus and relation of the virion proteins to the viral transcriptase.

Authors:  D H Bishop; P Roy
Journal:  J Virol       Date:  1972-08       Impact factor: 5.103

9.  Complete transcription by the transcriptase of vesicular stomatitis virus.

Authors:  D H Bishop
Journal:  J Virol       Date:  1971-04       Impact factor: 5.103

10.  Ribonucleic acid polymerase in virions of Newcastle disease virus: comparison with the vesicular stomatitis virus polymerase.

Authors:  A S Huang; D Baltimore; M A Bratt
Journal:  J Virol       Date:  1971-03       Impact factor: 5.103

View more
  9 in total

1.  Temperature-sensitive defect of vesicular stomatitis virus in complementation group II.

Authors:  A Combard; C Printz-Ane; C Martinet; P Printz
Journal:  J Virol       Date:  1977-03       Impact factor: 5.103

2.  Viral transcription is necessary and sufficient for vesicular stomatitis virus to inhibit maturation of small nuclear ribonucleoproteins.

Authors:  D E Crone; J D Keene
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

3.  Transcription of vesicular stomatitis virus is required to shut off cellular RNA synthesis.

Authors:  P K Weck; R R Wagner
Journal:  J Virol       Date:  1979-04       Impact factor: 5.103

4.  Further characterization of the replicative complex of vesicular stomatitis virus.

Authors:  C C Simonsen; V M Hill; D F Summers
Journal:  J Virol       Date:  1979-08       Impact factor: 5.103

5.  Envelope proteins and replication of vesicular stomatitis virus: in vivo effects of RNA+ temperature-sensitive mutations on viral RNA synthesis.

Authors:  C Martinet; A Combard; C Printz-Ané; P Printz
Journal:  J Virol       Date:  1979-01       Impact factor: 5.103

6.  Differential inhibition of host protein synthesis in L cells infected with RNA - temperature-sensitive mutants of vesicular stomatitis virus.

Authors:  P E McAllister; R R Wagner
Journal:  J Virol       Date:  1976-05       Impact factor: 5.103

7.  RNA- temperature-sensitive mutants of vesicular stomatitis virus: L-protein thermosensitivity accounts for transcriptase restriction of group I mutants.

Authors:  D M Hunt; S U Emerson; R R Wagner
Journal:  J Virol       Date:  1976-05       Impact factor: 5.103

8.  Temperature-sensitive mutants of vesicular stomatitis virus: comparison of the in vitro RNA polymerase defects of group I and group IV mutants.

Authors:  J S Ngan; A F Holloway; D V Cormack
Journal:  J Virol       Date:  1974-10       Impact factor: 5.103

9.  Pathogenicity and immunogenicity for mice of temperature-sensitive mutants of vesicular stomatitis virus.

Authors:  R R Wagner
Journal:  Infect Immun       Date:  1974-08       Impact factor: 3.441

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.